washingtonpost.com
Merck’s anti-covid pill, molnupiravir, was authorized by federal regulators a
day after Pfizer’s pill received a green light. Molnupiravir carries risks, but
with treatments in short supply, it may be the only option available.
over 3 years ago
washingtonpost.com
The study suggests a second booster may not yet be necessary.
about 3 years ago
washingtonpost.com
Progress toward a pediatric vaccine has been impatiently awaited by parents and
pediatricians.
about 3 years ago
washingtonpost.com
The rare cases aren’t severe but highlight the many questions that remain about
the virus.
almost 3 years ago
washingtonpost.com
The FDA announced that the fall shots would include a component from BA.4 and
BA.5, the omicron subvariants gaining ground in the United States.
almost 3 years ago
washingtonpost.com
Questions persist about the vaccine’s continued effectiveness against a swarm of later-generation versions of omicron.
over 2 years ago
washingtonpost.com
The shot increased the levels of antibodies that block the latest coronavirus subvariant.
over 2 years ago
washingtonpost.com
Scientists are unraveling the secrets of mummification – including the intriguing discovery that the practice may have been dependent on a global supply chain.
about 2 years ago
washingtonpost.com
For thousands of years, kimchi was fermented in earthenware vessels called “onggi.” Now, a pair of mechanical engineers have unraveled why.
about 2 years ago
washingtonpost.com
To unravel how malaria-carrying mosquitoes sniff out their next juicy meal, scientists set up a screened-in outdoor laboratory in Zambia.
almost 2 years ago
washingtonpost.com
To unravel how malaria-carrying mosquitoes sniff out their next juicy meal, scientists set up a screened-in outdoor laboratory in Zambia.
almost 2 years ago